GLP-1 receptor agonists promote weight loss by suppressing appetite, enhancing satiety (the feeling of fullness), and delaying gastric emptying
Seven additional phase 3 readouts are expected throughout this year, covering a range of conditions including type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic dysfunction-associated steatotic liver disease
Weight loss is typically fastest in the first 36 months , then slows but may continue gradually before plateauing around ~12 months or later
"Reta" is the colloquial shorthand for retatrutide, widely used in forums, social media, and search queries analogous to "tirz" for tirzepatide and "sema" for semaglutide
Boosts Elasticity and Collagen In that same 2019 study, researchers found that glutathione can boost skins elasticity
Energy levels often stabilize once the body adapts